Service hospitalier de psychiatrie : Questions médicales fréquentes
Nom anglais: Psychiatric Department, Hospital
Descriptor UI:D011567
Tree Number:N04.452.442.452.422.641
Termes MeSH sélectionnés :
C-Reactive Protein
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Service hospitalier de psychiatrie : Questions médicales les plus fréquentes",
"headline": "Service hospitalier de psychiatrie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Service hospitalier de psychiatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Service hospitalier de psychiatrie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Services hospitaliers",
"url": "https://questionsmedicales.fr/mesh/D006748",
"about": {
"@type": "MedicalCondition",
"name": "Services hospitaliers",
"code": {
"@type": "MedicalCode",
"code": "D006748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.442.452.422"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Service hospitalier de psychiatrie",
"alternateName": "Psychiatric Department, Hospital",
"code": {
"@type": "MedicalCode",
"code": "D011567",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giuseppe Nicolò",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Nicol%C3%B2",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Salute Mentale e Dipendenze Patologiche, ASL Roma 5."
}
},
{
"@type": "Person",
"name": "Michael P Wilson",
"url": "https://questionsmedicales.fr/author/Michael%20P%20Wilson",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, AR."
}
},
{
"@type": "Person",
"name": "Brittany M Gouse",
"url": "https://questionsmedicales.fr/author/Brittany%20M%20Gouse",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA; Wellness and Recovery After Psychosis Research Program, Boston Medical Center, Boston, MA 02118, USA. Electronic address: Brittany.gouse@bmc.org."
}
},
{
"@type": "Person",
"name": "Rachel Oblath",
"url": "https://questionsmedicales.fr/author/Rachel%20Oblath",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston 02118, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36268143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6833078"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35997934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12013-022-01089-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35714415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.talanta.2022.123661"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35821191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35766701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220236"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration d'établissement de santé",
"item": "https://questionsmedicales.fr/mesh/D058016"
},
{
"@type": "ListItem",
"position": 5,
"name": "Administration hospitalière",
"item": "https://questionsmedicales.fr/mesh/D006739"
},
{
"@type": "ListItem",
"position": 6,
"name": "Services hospitaliers",
"item": "https://questionsmedicales.fr/mesh/D006748"
},
{
"@type": "ListItem",
"position": 7,
"name": "Service hospitalier de psychiatrie",
"item": "https://questionsmedicales.fr/mesh/D011567"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Service hospitalier de psychiatrie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Service hospitalier de psychiatrie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Service hospitalier de psychiatrie",
"description": "Comment un diagnostic psychiatrique est-il établi ?\nQuels outils sont utilisés pour le diagnostic ?\nQuelles sont les principales catégories de troubles ?\nLe diagnostic peut-il changer avec le temps ?\nQui peut poser un diagnostic psychiatrique ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Service hospitalier de psychiatrie",
"description": "Quels sont les symptômes courants des troubles mentaux ?\nComment reconnaître une crise d'angoisse ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nQuels signes indiquent une dépression sévère ?\nLes symptômes physiques sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Service hospitalier de psychiatrie",
"description": "Comment prévenir les troubles mentaux ?\nLe soutien familial joue-t-il un rôle ?\nLes programmes scolaires peuvent-ils aider ?\nL'activité physique aide-t-elle à prévenir les troubles ?\nLes techniques de relaxation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Service hospitalier de psychiatrie",
"description": "Quels types de traitements sont disponibles en psychiatrie ?\nComment fonctionne la psychothérapie ?\nQuels médicaments sont couramment prescrits ?\nLa thérapie de groupe est-elle efficace ?\nQu'est-ce que la thérapie électroconvulsive ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Service hospitalier de psychiatrie",
"description": "Quelles complications peuvent survenir avec les troubles mentaux ?\nLes troubles mentaux augmentent-ils le risque de maladies physiques ?\nComment l'usage de substances affecte-t-il la santé mentale ?\nLes troubles mentaux peuvent-ils affecter la vie professionnelle ?\nQuelles sont les conséquences du suicide ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Service hospitalier de psychiatrie",
"description": "Quels sont les facteurs de risque des troubles mentaux ?\nLe stress au travail peut-il être un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?\nLes événements traumatiques augmentent-ils le risque ?\nL'isolement social est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D011567?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment un diagnostic psychiatrique est-il établi ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il repose sur des entretiens cliniques, des évaluations psychologiques et des critères DSM."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires, des échelles d'évaluation et des tests psychologiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles sont les principales catégories de troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles de l'humeur, anxieux, psychotiques et de la personnalité sont principaux."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il changer avec le temps ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut évoluer en fonction des symptômes et des réponses au traitement."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic psychiatrique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychiatre ou un professionnel de la santé mentale qualifié peut établir un diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles mentaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'anxiété, la dépression, les hallucinations et les troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise d'angoisse ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des palpitations, des sueurs, des tremblements et une peur intense."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut être très individuelle selon les personnes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dépression sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une perte d'intérêt, des troubles du sommeil, de l'appétit et des pensées suicidaires."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs corporelles et des troubles digestifs peuvent accompagner les troubles mentaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles mentaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien social et la gestion du stress."
}
},
{
"@type": "Question",
"name": "Le soutien familial joue-t-il un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien familial peut réduire le risque de troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent enseigner des compétences de vie et de gestion des émotions."
}
},
{
"@type": "Question",
"name": "L'activité physique aide-t-elle à prévenir les troubles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est bénéfique pour la santé mentale et le bien-être."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation et le yoga peuvent réduire le stress."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont disponibles en psychiatrie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la psychothérapie, la médication et les thérapies alternatives."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la psychothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à explorer les pensées et comportements pour améliorer le bien-être mental."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, anxiolytiques et antipsychotiques sont fréquemment utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle favorise le soutien social et l'échange d'expériences entre patients."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie électroconvulsive ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement pour les cas sévères de dépression, utilisant des impulsions électriques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les troubles mentaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'isolement social, les problèmes de santé physique et le suicide."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux augmentent-ils le risque de maladies physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent augmenter le risque de maladies cardiovasculaires et métaboliques."
}
},
{
"@type": "Question",
"name": "Comment l'usage de substances affecte-t-il la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'abus de substances peut aggraver les troubles mentaux et compliquer le traitement."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux peuvent-ils affecter la vie professionnelle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des absences, une baisse de productivité et des conflits."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences du suicide ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suicide a des conséquences dévastatrices pour la famille, les amis et la communauté."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles mentaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, le stress, les traumatismes et l'isolement social."
}
},
{
"@type": "Question",
"name": "Le stress au travail peut-il être un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement de travail stressant peut contribuer au développement de troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de troubles mentaux augmente le risque chez les individus."
}
},
{
"@type": "Question",
"name": "Les événements traumatiques augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes peuvent déclencher ou aggraver des troubles mentaux."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut exacerber les symptômes et augmenter le risque de troubles."
}
}
]
}
]
}
The prognostic role of CRP (C-reactive protein) in gynecological tumors has been previously reported in individual studies, but whether CRP can be used as a separate potential prognostic factor has no...
A systematic search was carried out to find the literature evaluating the predictive role of CRP in the prognosis of gynecological cancer patients. For the purpose of determining the relationship betw...
A total of 19 studies, including 4062 patients, were analyzed retrospectively. The FIGO stage was related to the CRP level (OR = 0.43, 95% CI: 0.19-1.00). Age, lymph node metastasis, and histological ...
CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer....
The acute phase C-reactive protein (CRP) is mainly synthesized and secreted by the liver in a cytokine-mediated response to infection or inflammation and circulates as a pentamer (pCRP) in plasma. Rec...
In this paper, we report on a novel fluorescent aptasensor based on aptamers modified by both nitrogen-doped graphene quantum dots (N-GQDs) and gold nanoparticles (AuNPs) for the detection of C-reacti...
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b...
ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(...
The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien...
In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...
Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ...
Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t...
Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign...
Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....
Life's Essential 8 (LE8) is a score that includes modifiable risk factors for cardiovascular disease. Four health behaviors (diet, physical activity, nicotine exposure and sleep health) and four healt...
We investigate the interactions between C-reactive protein (CRP) and new CRP-binding peptide materials using experimental (biological and physicochemical) methods with the support of theoretical simul...
To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with...
A retrospective study....
University-affiliated IVF center....
In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP...
Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation....
The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates....
The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern...
Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...
Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1...
A prospective, observational cohort study....
Children with sepsis and organ failure in nine pediatric intensive care units in the United States....
Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim...
Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr...
Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...
Social relationships are an important driver of health, and inflammation has been proposed as a key neurobiological mechanism to explain this effect. Behavioral researchers have focused on social rela...